Table of Contents

company-logo

ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity disorder; ABV-1703 has completed Phase I clinical trials for the treatment of pancreatic cancer; ABV-1702 has completed Phase I clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.

ABVC BioPharma Dividend Announcement

• ABVC BioPharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on ABVC BioPharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

ABVC BioPharma Dividend History

ABVC BioPharma Dividend Yield

ABVC BioPharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing ABVC BioPharma stock? Use our calculator to estimate your expected dividend yield:

ABVC BioPharma Financial Ratios

P/E ratio-0.52
PEG ratio-0.02
P/B ratio0.72
ROE-132.83%
Payout ratio0.00%
Current ratio0.33
Quick ratio0.33
Cash Ratio0.11

ABVC BioPharma Dividend FAQ

Does ABVC BioPharma stock pay dividends?
ABVC BioPharma does not currently pay dividends to its shareholders.
Has ABVC BioPharma ever paid a dividend?
No, ABVC BioPharma has no a history of paying dividends to its shareholders. ABVC BioPharma is not known for its dividend payments.
Why doesn't ABVC BioPharma pay dividends?
There are several potential reasons why ABVC BioPharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will ABVC BioPharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While ABVC BioPharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is ABVC BioPharma a dividend aristocrat?
ABVC BioPharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is ABVC BioPharma a dividend king?
ABVC BioPharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is ABVC BioPharma a dividend stock?
No, ABVC BioPharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy ABVC BioPharma stocks?
To buy ABVC BioPharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy ABVC BioPharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.